News Image

NYSE:CB is not too expensive for the growth it is showing.

By Mill Chart

Last update: Mar 22, 2024

Our stock screener has singled out CHUBB LTD (NYSE:CB) as an attractive growth opportunity. NYSE:CB is demonstrating remarkable growth potential while maintaining strong financial indicators, making it a reasonably priced option. We'll explore this further.

Unpacking NYSE:CB's Growth Rating

Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NYSE:CB boasts a 7 out of 10:

  • CB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.05%, which is quite impressive.
  • Measured over the past years, CB shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.97% on average per year.
  • The Revenue has grown by 15.45% in the past year. This is quite good.
  • The Revenue has been growing by 8.70% on average over the past years. This is quite good.
  • Based on estimates for the next years, CB will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.11% on average per year.
  • The Revenue is expected to grow by 9.90% on average over the next years. This is quite good.

Assessing Valuation for NYSE:CB

ChartMill provides a Valuation Rating to every stock, ranging from 0 to 10. This rating assesses various valuation aspects, comparing price to earnings and cash flows, while considering factors like profitability and growth. NYSE:CB boasts a 5 out of 10:

  • CB's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.19.
  • A Price/Forward Earnings ratio of 11.46 indicates a reasonable valuation of CB.
  • CB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.59.
  • CB has a very decent profitability rating, which may justify a higher PE ratio.

Assessing Health Metrics for NYSE:CB

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NYSE:CB scores a 5 out of 10:

  • There is no outstanding debt for CB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

Profitability Examination for NYSE:CB

ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NYSE:CB scores a 6 out of 10:

  • CB's Return On Assets of 3.94% is fine compared to the rest of the industry. CB outperforms 77.70% of its industry peers.
  • Looking at the Return On Equity, with a value of 15.17%, CB is in the better half of the industry, outperforming 71.94% of the companies in the same industry.
  • The Profit Margin of CB (18.15%) is better than 81.30% of its industry peers.
  • CB's Profit Margin has improved in the last couple of years.
  • CB has a Operating Margin of 19.53%. This is in the better half of the industry: CB outperforms 77.70% of its industry peers.
  • In the last couple of years the Operating Margin of CB has grown nicely.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

Our latest full fundamental report of CB contains the most current fundamental analsysis.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back